{"id":"https://openalex.org/W3207147702","doi":"https://doi.org/10.1016/j.jns.2021.117847","title":"Lecanemab, an anti-A\u03b2 protofibril antibody: Updated data from a randomized, double-blind phase 2B proof of concept clinical trial and open-label extension in early Alzheimer's disease","display_name":"Lecanemab, an anti-A\u03b2 protofibril antibody: Updated data from a randomized, double-blind phase 2B proof of concept clinical trial and open-label extension in early Alzheimer's disease","publication_year":2021,"publication_date":"2021-10-01","ids":{"openalex":"https://openalex.org/W3207147702","doi":"https://doi.org/10.1016/j.jns.2021.117847","mag":"3207147702"},"language":"en","primary_location":{"id":"doi:10.1016/j.jns.2021.117847","doi":"https://doi.org/10.1016/j.jns.2021.117847","is_oa":false,"landing_page_url":"https://doi.org/10.1016/j.jns.2021.117847","pdf_url":null,"source":{"id":"https://openalex.org/S169054600","display_name":"Journal of the Neurological Sciences","issn_l":"0022-510X","issn":["0022-510X","1878-5883"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of the Neurological Sciences","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5075884817","display_name":"Chad J. Swanson","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210151718","display_name":"Eisai (United States)","ror":"https://ror.org/0469x1750","country_code":"US","type":"company","lineage":["https://openalex.org/I4210151718","https://openalex.org/I55881946"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Chad Swanson","raw_affiliation_strings":["Eisai Inc, Nbg, Woodcliff Lake, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Eisai Inc, Nbg, Woodcliff Lake, United States","institution_ids":["https://openalex.org/I4210151718"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5031104672","display_name":"Shobha Dhadda","orcid":"https://orcid.org/0000-0002-7290-7168","observed_orcids":["https://orcid.org/0000-0002-7290-7168"]},"institutions":[{"id":"https://openalex.org/I4210151718","display_name":"Eisai (United States)","ror":"https://ror.org/0469x1750","country_code":"US","type":"company","lineage":["https://openalex.org/I4210151718","https://openalex.org/I55881946"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Shobha Dhadda","raw_affiliation_strings":["Eisai Inc, Nbg, Woodcliff Lake, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Eisai Inc, Nbg, Woodcliff Lake, United States","institution_ids":["https://openalex.org/I4210151718"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5007964614","display_name":"Mark Hodgkinson","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210148122","display_name":"Eisai (United Kingdom)","ror":"https://ror.org/054j7wb83","country_code":"GB","type":"company","lineage":["https://openalex.org/I4210148122","https://openalex.org/I55881946"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Mark Hodgkinson","raw_affiliation_strings":["Eisai Ltd, Inc, Nbg, Hatfield, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Eisai Ltd, Inc, Nbg, Hatfield, United Kingdom","institution_ids":["https://openalex.org/I4210148122"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100432955","display_name":"David Xinzheyang Li","orcid":"https://orcid.org/0000-0002-1028-8445","observed_orcids":["https://orcid.org/0000-0002-1028-8445"]},"institutions":[{"id":"https://openalex.org/I4210151718","display_name":"Eisai (United States)","ror":"https://ror.org/0469x1750","country_code":"US","type":"company","lineage":["https://openalex.org/I4210151718","https://openalex.org/I55881946"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"David Li","raw_affiliation_strings":["Eisai Inc, Nbg, Woodcliff Lake, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Eisai Inc, Nbg, Woodcliff Lake, United States","institution_ids":["https://openalex.org/I4210151718"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5002568639","display_name":"Michio Kanekiyo","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210151718","display_name":"Eisai (United States)","ror":"https://ror.org/0469x1750","country_code":"US","type":"company","lineage":["https://openalex.org/I4210151718","https://openalex.org/I55881946"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Michio Kanekiyo","raw_affiliation_strings":["Eisai Inc, Nbg, Woodcliff Lake, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Eisai Inc, Nbg, Woodcliff Lake, United States","institution_ids":["https://openalex.org/I4210151718"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5090798839","display_name":"June M. Kaplow","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210151718","display_name":"Eisai (United States)","ror":"https://ror.org/0469x1750","country_code":"US","type":"company","lineage":["https://openalex.org/I4210151718","https://openalex.org/I55881946"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"June Kaplow","raw_affiliation_strings":["Eisai Inc, Nbg, Woodcliff Lake, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Eisai Inc, Nbg, Woodcliff Lake, United States","institution_ids":["https://openalex.org/I4210151718"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103998068","display_name":"Martin P. Rabe","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210151718","display_name":"Eisai (United States)","ror":"https://ror.org/0469x1750","country_code":"US","type":"company","lineage":["https://openalex.org/I4210151718","https://openalex.org/I55881946"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Martin Rabe","raw_affiliation_strings":["Eisai Inc, Nbg, Woodcliff Lake, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Eisai Inc, Nbg, Woodcliff Lake, United States","institution_ids":["https://openalex.org/I4210151718"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5032313383","display_name":"Helena Heanue\u2010Travers","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210148122","display_name":"Eisai (United Kingdom)","ror":"https://ror.org/054j7wb83","country_code":"GB","type":"company","lineage":["https://openalex.org/I4210148122","https://openalex.org/I55881946"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Helena Heanue-Travers","raw_affiliation_strings":["Eisai Ltd, Inc, Nbg, Hatfield, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Eisai Ltd, Inc, Nbg, Hatfield, United Kingdom","institution_ids":["https://openalex.org/I4210148122"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Robert Gordon","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210148122","display_name":"Eisai (United Kingdom)","ror":"https://ror.org/054j7wb83","country_code":"GB","type":"company","lineage":["https://openalex.org/I4210148122","https://openalex.org/I55881946"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Robert Gordon","raw_affiliation_strings":["Eisai Ltd, Inc, Nbg, Hatfield, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Eisai Ltd, Inc, Nbg, Hatfield, United Kingdom","institution_ids":["https://openalex.org/I4210148122"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113065527","display_name":"Robert Y. K. Lai","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210148122","display_name":"Eisai (United Kingdom)","ror":"https://ror.org/054j7wb83","country_code":"GB","type":"company","lineage":["https://openalex.org/I4210148122","https://openalex.org/I55881946"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Robert Lai","raw_affiliation_strings":["Eisai Ltd, Inc, Nbg, Hatfield, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Eisai Ltd, Inc, Nbg, Hatfield, United Kingdom","institution_ids":["https://openalex.org/I4210148122"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109576366","display_name":"Lynn Darden Kramer","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210151718","display_name":"Eisai (United States)","ror":"https://ror.org/0469x1750","country_code":"US","type":"company","lineage":["https://openalex.org/I4210151718","https://openalex.org/I55881946"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Lynn Kramer","raw_affiliation_strings":["Eisai Inc, Nbg, Woodcliff Lake, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Eisai Inc, Nbg, Woodcliff Lake, United States","institution_ids":["https://openalex.org/I4210151718"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5064852158","display_name":"Larisa Reyderman","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210151718","display_name":"Eisai (United States)","ror":"https://ror.org/0469x1750","country_code":"US","type":"company","lineage":["https://openalex.org/I4210151718","https://openalex.org/I55881946"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Larisa Reyderman","raw_affiliation_strings":["Eisai Inc, Nbg, Woodcliff Lake, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Eisai Inc, Nbg, Woodcliff Lake, United States","institution_ids":["https://openalex.org/I4210151718"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":3250,"currency":"USD","value_usd":3250},"apc_paid":null,"fwci":0.4735,"has_fulltext":false,"cited_by_count":4,"citation_normalized_percentile":{"value":0.6172229,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":93,"max":97},"biblio":{"volume":"429","issue":null,"first_page":"117847","last_page":"117847"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10086","display_name":"Alzheimer's disease research and treatments","score":0.9984999895095825,"subfield":{"id":"https://openalex.org/subfields/2737","display_name":"Physiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10086","display_name":"Alzheimer's disease research and treatments","score":0.9984999895095825,"subfield":{"id":"https://openalex.org/subfields/2737","display_name":"Physiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10009","display_name":"Dementia and Cognitive Impairment Research","score":0.001500000013038516,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12023","display_name":"Cholinesterase and Neurodegenerative Diseases","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/lecanemab","display_name":"lecanemab","score":0.9980000257492065},{"id":"https://openalex.org/keywords/anti-amyloid-beta-antibodies","display_name":"anti-amyloid beta antibodies","score":0.7260000109672546},{"id":"https://openalex.org/keywords/amyloid-beta-protofibrils","display_name":"amyloid-beta protofibrils","score":0.8640000224113464},{"id":"https://openalex.org/keywords/early-alzheimer-s-disease","display_name":"early Alzheimer's disease","score":0.9480000138282776},{"id":"https://openalex.org/keywords/amyloid-fibril-formation","display_name":"amyloid fibril formation","score":0.527999997138977},{"id":"https://openalex.org/keywords/anti-amyloid-therapy","display_name":"anti-amyloid therapy","score":0.6480000019073486},{"id":"https://openalex.org/keywords/efficacy","display_name":"efficacy","score":0.4000000059604645},{"id":"https://openalex.org/keywords/safety","display_name":"safety","score":0.9789999723434448},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.9670000076293945},{"id":"https://openalex.org/keywords/pharmacodynamics","display_name":"pharmacodynamics","score":0.6269999742507935},{"id":"https://openalex.org/keywords/open-label-extension","display_name":"open-label extension","score":0.765999972820282}],"concepts":[{"id":"https://openalex.org/C3019800554","wikidata":"https://www.wikidata.org/wiki/Q3813242","display_name":"Open label","level":3,"score":0.7243884205818176},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.5643038749694824},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5289801359176636},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.5214276313781738},{"id":"https://openalex.org/C2991744798","wikidata":"https://www.wikidata.org/wiki/Q608510","display_name":"Double blind","level":4,"score":0.5061816573143005},{"id":"https://openalex.org/C2778029271","wikidata":"https://www.wikidata.org/wiki/Q5421931","display_name":"Extension (predicate logic)","level":2,"score":0.5024278163909912},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.329659104347229},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.3078765869140625},{"id":"https://openalex.org/C41008148","wikidata":"https://www.wikidata.org/wiki/Q21198","display_name":"Computer science","level":0,"score":0.3031875491142273},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.2572707533836365},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.13212478160858154},{"id":"https://openalex.org/C27081682","wikidata":"https://www.wikidata.org/wiki/Q269829","display_name":"Placebo","level":3,"score":0.0},{"id":"https://openalex.org/C199360897","wikidata":"https://www.wikidata.org/wiki/Q9143","display_name":"Programming language","level":1,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1016/j.jns.2021.117847","doi":"https://doi.org/10.1016/j.jns.2021.117847","is_oa":false,"landing_page_url":"https://doi.org/10.1016/j.jns.2021.117847","pdf_url":null,"source":{"id":"https://openalex.org/S169054600","display_name":"Journal of the Neurological Sciences","issn_l":"0022-510X","issn":["0022-510X","1878-5883"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of the Neurological Sciences","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9922999739646912,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Clinical Trial","id":"https://openalex.org/study-designs/clinical-trial"}],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4205131272","https://openalex.org/W3152692563","https://openalex.org/W4396517053","https://openalex.org/W4212945886","https://openalex.org/W4312128797","https://openalex.org/W4312087820","https://openalex.org/W4389729912","https://openalex.org/W4319461701","https://openalex.org/W4388947495","https://openalex.org/W4406225061"],"abstract_inverted_index":null,"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2023,"cited_by_count":3}],"updated_date":"2026-09-29T14:09:16.559479","created_date":"2021-10-25T00:00:00"}